Germany's Bayer, whose US assets were sequestered after World War I, is said to be eyeing the possibility of buying the Sterling business, which uses the Bayer trade name for aspirin in the USA, and which Eastman Kodak has said it wants to sell. Reporting this, Business Week also notes that Bayer is keen to expand its over-the-counter medicines business in the USA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze